Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Lavender, Nicole A ^a   Rogers, Erica N ^a   Yeyeodu, Susan ^b   Rudd, James ^b   Hu, Ting ^e   Zhang, Jie ^d   Brock, Guy N ^d   Kimbro, Kevin S ^b   Moore, Jason H ^c   Hein, David W ^a   Kidd, La Creis R ^a,e  

^a University of Louisville School of Medicine   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d School of Public Health Information Sciences (SPHIS)   (United States)

^e Clinical and Translational Research Building ^*  (United States)

Author keywords

Apoptosis; Gene gene interactions; Multifactor dimensionality reduction (MDR); Prostate cancer; Single nucleotide polymorphisms; Statistical epistasis networks (SEN)

Indexed keywords

ADULT; AGED; AKT3 GENE; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FUNCTION; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC VARIABILITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; ONCOGENE; PRIORITY JOURNAL; PRKCQ GENE; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL EPISTASIS NETWORK; CASE CONTROL STUDY; ENTROPY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL;

CITRUS MACROPHYLLA;

PROTEIN KINASE B;

AGED; AGED, 80 AND OVER; APOPTOSIS; CASE-CONTROL STUDIES; ENTROPY; GENETIC VARIATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIFACTOR DIMENSIONALITY REDUCTION; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RISK FACTORS;

EID: 84861127770     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-11     Document Type: Article

References (75)

1. Cancer Facts and Figures 2012. American Cancer S, Atlanta, Georgia: American Cancer Society 2012
2. Apoptosis and cell death channels in prostate cancer. Tapia-Vieyra JV, Mas-Oliva J, ArchMedRes 2001 32 3 175 185 (Pubitemid 32499529)
3. Carcinogenesis and apoptosis: paradigms and paradoxes. Zhivotovsky B, Orrenius S, Carcinogenesis 2006 27 10 1939 1945 (Pubitemid 44530567)
4. Apoptosis, reproductive failure, and oxidative stress in Chinese hamster ovary cells with compromised genomic integrity. Limoli CL, Hartmann A, Shephard L, Yang CR, Boothman DA, Bartholomew J, Morgan WF, Cancer Res 1998 58 16 3712 3718 (Pubitemid 28376573)
5. Cell death: critical control points. Danial NN, Korsmeyer SJ, Cell 2004 116 2 205 219 (Pubitemid 38167313)
6. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Furuya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT, Clinical cancer research: an official journal of the American Association for Cancer Research 1996 2 2 389 398 (Pubitemid 26075642)
7. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R, Am J Pathol 1993 143 2 390 400 (Pubitemid 24058194)
8. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML, Cancer Res 1992 52 24 6940 6944 (Pubitemid 23006303)
9. Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene. Fleischmann A, Huland H, Mirlacher M, Wilczak W, Simon R, Erbersdobler A, Sauter G, Schlomm T, The Prostate 2011 doi: 10.1002/pros.21504
10. Molecular genetics of prostate cancer. Abate-Shen C, Shen MM, Genes Dev 2000 14 19 2410 2434
11. p53 expression and clinical outcome in prostate cancer. Thomas DJ, Robinson M, King P, Hasan T, Charlton R, Martin J, Carr TW, Neal DE, Br J Urol 1993 72 5 Pt 2 778 781 (Pubitemid 24000141)
12. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer. Shurbaji MS, Kalbfleisch JH, Thurmond TS, Hum Pathol 1995 26 1 106 109
13. p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy. Stackhouse GB, Sesterhenn IA, Bauer JJ, Mostofi FK, Connelly RR, Srivastava SK, Moul JW, J Urol 1999 162 6 2040 2045
14. Apoptosis regulators Fau and Bcl-G are down-regulated in prostate cancer. Pickard MR, Edwards SE, Cooper CS, Williams GT, Prostate 2010 70 14 1513 1523
15. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, et al. Cell 2007 129 6 1065 1079 (Pubitemid 46891036)
16. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Guo JP, Shu SK, He L, Lee YC, Kruk PA, Grenman S, Nicosia SV, Mor G, Schell MJ, Coppola D, et al. Am J Pathol 2009 175 1 324 333
17. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells. Hill KM, Kalifa S, Das JR, Bhatti T, Gay M, Williams D, Taliferro-Smith L, De Marzo AM, Prostate 2010 70 7 755 764
18. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV, J Cell Sci 2002 115 Pt 1 141 151 (Pubitemid 34105537)
19. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, Zhang J, Signoretti S, Loda M, Roberts TM, et al. Nature 2008 454 7205 776 779
20. p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, McLauchlin A, Josey D, Bonney G, Dunston GM, Prostate 2010 70 16 1739 1745
21. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Srivastava K, Srivastava A, Sharma KL, Mittal B, Mutat Res 2011 728 1-2 67 79
22. Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer. Lee EB, Jeon HS, Yoo SS, Choi YY, Kang HG, Cho S, Cha SI, Choi JE, Park TI, Lee BH, et al. Ann Surg Oncol 2010 17 10 2608 2618
23. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, Parker MI, Mathew CG, Carcinogenesis 2011 32 12 1855 1861
24. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, et al. J National Cancer Inst 2011 103 16 1252 1263
25. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, et al. Hum Mol Genet 2011 20 16 3289 3303
26. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 18 11 3044 3048
27. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Sergentanis TN, Economopoulos KP, Breast Cancer Res Treat 2010 120 1 229 234
28. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Enjuanes A, Benavente Y, Bosch F, Martin-Guerrero I, Colomer D, Perez-Alvarez S, Reina O, Ardanaz MT, Jares P, Garcia-Orad A, et al. Cancer Res 2008 68 24 10178 10186
29. Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists. Sigurdson AJ, Bhatti P, Doody MM, Hauptmann M, Bowen L, Simon SL, Weinstock RM, Linet MS, Rosenstein M, Stovall M, et al. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 16 10 2000 2007 (Pubitemid 47621173)
30. A common coding variant in CASP8 is associated with breast cancer risk. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, et al. Nat Genet 2007 39 3 352 358 (Pubitemid 46328496)
31. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, Wang SS, Berndt SI, Zahm SH, Holford TR, Leaderer B, et al. Carcinogenesis 2007 28 4 823 827 (Pubitemid 46523339)
32. A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer. Lou Y, Fang CQ, Li JH, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007 24 1 59 62
33. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. Consortium BCA, J National Cancer Inst 2006 98 19 1382 1396
34. Polymorphisms of nuclear factor-kappaB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens. Du J, Huo J, Shi J, Yuan Z, Zhang C, Fu W, Jiang H, Yi Q, Hou J, Haematologica 2011 96 5 729 737
35. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, Wang ZL, Jia CR, Carstensen J, Sun XF, Scand J Gastroenterol 2007 42 3 345 350
36. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. Schildkraut JM, Iversen ES, Wilson MA, Clyde MA, Moorman PG, Palmieri RT, Whitaker R, Bentley RC, Marks JR, Berchuck A, PLoS One 2010 5 4 10061
37. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM, Carcinogenesis 2007 28 8 1680 1686 (Pubitemid 47289028)
38. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, et al. Nat Genet 2007 39 5 645 649 (Pubitemid 46676108)
39. Characterizing genetic interactions in human disease association studies using statistical epistasis networks. Hu T, Sinnott-Armstrong NA, Kiralis JW, Andrew AS, Karagas MR, Moore JH, BMC Bioinforma 2011 12 364
40. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey KT, Holly EA, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 17 6 1470 1479
41. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Mason RA, Morlock EV, Karagas MR, Kelsey KT, Marsit CJ, Schned AR, Andrew AS, Carcinogenesis 2009 30 7 1155 1160
42. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, et al. HumHered 2008 65 2 105 118 (Pubitemid 350036684)
43. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR, Carcinogenesis 2006 27 5 1030 1037
44. Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, Moore JH, Hein DW, Kidd LC, BMC Cancer 2009 9 397
45. No association between variant DNA repair genes and prostate cancer risk among men of African descent. Lavender NA, Komolafe OO, Benford M, Brock G, Moore JH, Vancleave TT, States JC, Kittles RA, Kidd LC, Prostate 2010 70 2 113 119
46. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Chen M, Kamat AM, Huang M, Grossman HB, Dinney CP, Lerner SP, Wu X, Gu J, Carcinogenesis 2007 28 10 2160 2165 (Pubitemid 47543377)
47. 8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study. Benford ML, VanCleave TT, Lavender NA, Kittles RA, Kidd LR, BMC Cancer 2010 10 334
48. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW Jr, Kittles RA, Kidd LC, Prostate 2010 70 4 341 352
49. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ, Roth RA, J Biol Chem 1999 274 31 21528 21532
50. Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. Bauer B, Krumbock N, Fresser F, Hochholdinger F, Spitaler M, Simm A, Uberall F, Schraven B, Baier G, J Biol Chem 2001 276 34 31627 31634
51. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer. Wang M, Cheng G, Zhang Z, Fu G, Mutat Res 2009 661 1-2 85 92
52. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA, Clinical cancer research: an official journal of the American Association for Cancer Research 2005 11 23 8391 8397 (Pubitemid 41746952)
53. TNF superfamily gene polymorphism as prognostic factor in early breast cancer. Jung JH, Chae YS, Moon JH, Kang BW, Kim JG, Sohn SK, Park JY, Lee MH, Park HY, J Cancer Res Clin Oncol 2010 136 5 685 694
54. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer. Kidd LR, Coulibaly A, Templeton TM, Chen W, Long LO, Mason T, Bonilla C, Akereyeni F, Freeman V, Isaacs W, et al. Prostate Cancer ProstaticDis 2006 9 3 284 292 (Pubitemid 44317264)
55. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Ritchie MD, Hahn LW, Moore JH, Genetic epidemiology 2003 24 2 150 157 (Pubitemid 36158211)
56. Failure to replicate a genetic association may provide important clues about genetic architecture. Greene CS, Penrod NM, Williams SM, Moore JH, PLoS One 2009 4 6 5639
57. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Gohagan JK, Prorok PC, Hayes RB, Kramer BS, Control ClinTrials 2000 21 6 Suppl 251S 272S
58. Methods for etiologic and early marker investigations in the PLCO trial. Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, et al. MutatRes 2005 592 1-2 147 154 (Pubitemid 41714051)
59. KEGG for linking genomes to life and the environment. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. Nucleic Acids Res 2008 36 Database 480 D484
60. From genomics to chemical genomics: new developments in KEGG. Kanehisa M, Goto S, Hattori M, oki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M, Nucleic Acids Res 2006 34 Database 354 D357
61. KEGG: kyoto encyclopedia of genes and genomes. Kanehisa M, Goto S, Nucleic Acids Res 2000 28 1 27 30 (Pubitemid 30047706)
62. Ingenuity Systems. 2008
63. Biocarta LLC. 2000
64. National Center for Biotechnology Information. 2011
65. Prostate cancer risk associated loci in African Americans. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, et al. Cancer EpidemiolBiomarkers Prev 2009 18 7 2145 2149
66. PGA: power calculator for case-control genetic association analyses. Menashe I, Rosenberg PS, Chen BE, BMC Genet 2008 9 36
67. Spatially uniform relieff (SURF) for computationally-efficient filtering of gene-gene interactions. Greene CS, Penrod NM, Kiralis J, Moore JH, BioData mining 2009 2 1 5
68. Bioinformatics challenges for genome-wide association studies. Moore JH, Asselbergs FW, Williams SM, Bioinformatics 2010 26 4 445 455
69. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC, J Theor Biol 2006 241 2 252 261 (Pubitemid 43993963)
70. A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH, Hum Hered 2010 70 3 219 225
71. Multivariate information transmission. McGill WL, Psychometrika vol 1954 19 97 116
72. Analyzing attribute interations. Jakulin A, Bratko I, Lecture Notes in Artificial Intelligence 2003 2838 229
73. Attribute interactions in medical data analysis. Jakulin A, Bratko I, Smrke D, Demsar J, Supan B, Lecture Notes in Artificial Intelligence 2003 2780 229
74. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC, JTheorBiol 2006 241 2 252 261 (Pubitemid 43993963)
75. Visualization-based cancer microarray data classification analysis. Mramor M, Leban G, Demsar J, Zupan B, Bioinformatics 2007 23 16 2147 2154 (Pubitemid 47394115)